欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5846/001
药品名称Lamotrigine Syri Pharma 10mg/ml, oral suspension
活性成分
    • Lamotrigine 10.0 mg/ml
剂型Oral suspension
上市许可持有人Syri Pharma Limited 1 Windmill Lane D02 F206 Dublin 2 Co. Dublin Ireland
参考成员国 - 产品名称Netherlands (NL)
Lamotrigine Syri Pharma 10mg/ml, suspensie voor oraal gebruik
互认成员国 - 产品名称
    • Germany (DE)
      Lamotrigin Desitin 10 mg/ml Suspension zum Einnehmen
    • Ireland (IE)
许可日期2024/11/20
最近更新日期2024/11/25
药物ATC编码
    • N03AX09 lamotrigine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Hybrid application (Art 10.3 Dir 2001/83/EC)
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase